Open original FDA record ↗Recall record
- FDA identifier
- Z-1206-2019
- Company in FDA record
- Arthrex, Inc.
- FDA record creation date
- Apr 23, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Devices may generate excessive heat during use.
Source facts
- Action
- On January 14, 2019, the firm, Arthrex, sent an "URGENT: VOLUNTARY PRODUCT RECALL NOTIFICATIONS" to all firms that received this device. The letter described the product, problem and actions to be taken. The customers were instructed to do the following: 1. Immediately discontinue use, sale, and distribution of the affected product 2. Direct customers: a) Please contact Arthrex Product Surveillance at 866-267-9138 or complaints@arthrex.com. Our Product Surveillance Specialists are available to answer questions regarding credit for affected devices in your possession. b) You do not need to notify any patients of this product recall. 3. Arthrex Agencies: a) Please contact FLS@arthrex.com as soon as possible to arrange for return of the affected product. b) You do not need to notify any customers as Arthrex will be notifying customers directly . 4. If you have any questions about this product recall, please contact Arthrex Product Surveillance at 866-267-9138 or complaints@art hrex.com .
- Initiated
- 2019-01-14
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2023-08-31
- Distribution
- Worldwide Distribution: US (nationwide) to states of: AL, AZ, CA, CO, DC, FL, GA, HI, IA, ID, IL, KY, LA, MA, MD, MI, MN, MO, NC, ND, NH, NY, OH, OK, PA, RI, SC, SD, TN, TX, VA, WA, WI, and WY; and to countries of: Germany, Brazil and Australia.
- Recall number
- Z-1206-2019
- Recall status
- Terminated
- CDRH record ID
- 170559
- FDA record created
- 2019-04-23
- Recall event number
- 82009